Trade-off between lower or higher oxygen saturations for extremely preterm infants: the first benefits of oxygen saturation targeting (BOOST) II trial reports its primary outcome

Affiliations

¹ Department of Clinical Epidemiology and Biostatistics, McMaster University; Division of Neonatology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: barbara.schmidt@uphs.upenn.edu.
² Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
³ Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

Editorial

Barbara Schmidt et al. J Pediatr. 2014 Jul.

. 2014 Jul;165(1):6-8.

doi: 10.1016/j.jpeds.2014.03.004. Epub 2014 Apr 14.

¹ Department of Clinical Epidemiology and Biostatistics, McMaster University; Division of Neonatology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: barbara.schmidt@uphs.upenn.edu.
² Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
³ Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

No abstract available

Comment on

Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes.
Darlow BA, Marschner SL, Donoghoe M, Battin MR, Broadbent RS, Elder MJ, Hewson MP, Meyer MP, Ghadge A, Graham P, McNeill NJ, Kuschel CA, Tarnow-Mordi WO; Benefits Of Oxygen Saturation Targeting-New Zealand (BOOST-NZ) Collaborative Group. Darlow BA, et al. J Pediatr. 2014 Jul;165(1):30-35.e2. doi: 10.1016/j.jpeds.2014.01.017. Epub 2014 Feb 20. J Pediatr. 2014. PMID: 24560181 Clinical Trial.